Additionally, the risk scores were notably different among stratified patients, with high‐risk scores in high‐grade glioma, wild‐type IDH, 1p19q non‐codeletion, mesenchymal subtype and MGMT promoter unmethylated patients (Figure 3G‐N, Figure S4A‐D). The gene discussed is MGMT; the disease is central nervous system cancer.